Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 22Terminated 9Recruiting 8Unknown 7Active not recruiting 6Withdrawn 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 40Breast Neoplasms 38Prostatic Neoplasms 24Colorectal Neoplasms 23Uterine Cervical Neoplasms 16Carcinoma, Non-Small-Cell Lung 13Anxiety Disorders 13Stomach Neoplasms 9Lymphoma, Follicular 9Leukemia, Myeloid, Acute 9Carcinoma, Hepatocellular 9Brain Neoplasms 9Lung Neoplasms 8Head and Neck Neoplasms 8Urinary Bladder Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Esophageal Neoplasms 7Sarcoma 6Ovarian Neoplasms 6Esophageal Squamous Cell Carcinoma 6Depression 6Colonic Neoplasms 6Uterine Cervical Dysplasia 5Small Cell Lung Carcinoma 5Pain 5Glioma 5Epilepsy 5Dementia 5Cholangiocarcinoma 5Squamous Cell Carcinoma of Head and Neck 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Interventional × Neoplasms, Glandular and Epithelial × Clear all
NCT04755517 2025-01-13

HPV400

Tampere University Hospital

Phase NA Enrolling by invitation
14,000 enrolled
Gynecologic

Carcinoma, Carcinoma in Situ, Uterine Cervical Dysplasia, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Adenocarcinoma in Situ

Data powered by HemOnc (CC BY 4.0) Colophon âš¡